Published in N J Med on August 01, 1989
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol (2003) 2.63
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A (1985) 2.33
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol (2012) 2.09
Disseminated intravascular coagulation (DIC): an approach. Am J Med (1972) 1.87
Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (1981) 1.84
Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol (2001) 1.72
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol (1977) 1.57
Risk factors for cancer of the testis. N Engl J Med (1980) 1.57
Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases. Cancer (1983) 1.54
Autopsy findings with permanent pervenous pacemakers. Circulation (1969) 1.53
Human papillomavirus infection. Frequency and association with cervical neoplasia in a young population. Acta Cytol (1989) 1.52
Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases. Hum Pathol (1970) 1.46
Insular carcinoid primary in the ovary. A clinicopathologic analysis of 48 cases. Cancer (1975) 1.36
Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol (1974) 1.33
Cancer risk in women exposed to diethylstilbestrol in utero. JAMA (1998) 1.32
The gelatinous bone marrow (serous atrophy) in patients with acquired immunodeficiency syndrome. Evidence of excess sulfated glycosaminoglycan. Arch Pathol Lab Med (1992) 1.31
Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst (2001) 1.30
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol (1999) 1.28
Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am J Obstet Gynecol (1984) 1.27
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol (2000) 1.27
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer (1980) 1.22
The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? Am J Obstet Gynecol (1991) 1.22
Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol (1995) 1.19
Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control (2001) 1.17
Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med (1975) 1.14
Endogenous opiate receptor ligand: electrically induced release in the guinea pig ileum. Science (1977) 1.14
Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum Pathol (1987) 1.12
Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet Gynecol (1979) 1.12
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer (2006) 1.11
Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol (2006) 1.11
Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies. Lancet (1981) 1.10
Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma. Ann Oncol (2010) 1.08
Antithymocyte globulin reacts with many normal human cell types. Blood (1983) 1.06
Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine (Baltimore) (1988) 1.06
Uveitis, cutaneous and neurosarcoid: treatment with low-dose cyclosporine A. Transplant Proc (1988) 1.04
Computer-assisted pathology encoding and reporting system (CAPER). Am J Clin Pathol (1977) 1.04
Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival. Ann Oncol (2009) 1.04
Tinctorial and morphologic properties distinguishing actinomycosis and nocardiosis. N Engl J Med (1970) 1.03
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study. Br J Cancer (2008) 1.02
Biological and immunological characterization of ATG and ALG. Blood (1986) 1.02
Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol (1978) 1.02
Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases. Hum Pathol (1972) 1.01
Endometrial cancer: stage at diagnosis and associated factors in black and white patients. Am J Obstet Gynecol (1995) 1.00
Carcinoid metastatic to the ovary. A clinocopathologic analysis of 35 cases. Cancer (1974) 1.00
Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy. Obstet Gynecol (1979) 1.00
Bladder cancer: race differences in extent of disease at diagnosis. Cancer (2000) 0.99
The skin in disseminated intravascular coagulation. Prospective analysis of thirty-six cases. Br J Dermatol (1973) 0.99
The embryologic development of the human vagina. Am J Obstet Gynecol (1976) 0.98
Normal development of the human female reproductive tract and alterations resulting from experimental exposure to diethylstilbestrol. Hum Pathol (1982) 0.97
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease. J Clin Oncol (1987) 0.97
Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr (1979) 0.97
Vaginal adenosis and other diethylstilbestrol-related abnormalities. Clin Obstet Gynecol (1975) 0.97
Disseminated intravascular coagulation: a reappraisal. Annu Rev Med (1979) 0.96
Central retinal vein occlusion: review of management. Eur J Ophthalmol (1999) 0.96
Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. J Pediatr (1975) 0.95
A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med (1984) 0.95
Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Blood (1985) 0.94
Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood. Proc Natl Acad Sci U S A (1985) 0.94
Female adnexal tumor of probable Wolffian origin with multiple recurrences over 16 years. Cancer (1985) 0.94
Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. Br J Cancer (2009) 0.93
Glassy cell carcinoma of the cervix. Cancer (1976) 0.93
Signet-ring cell carcinoma of the endometrium: a primary tumor masquerading as a metastasis. Int J Gynecol Pathol (1997) 0.93
Epithelial inclusion cyst of the iris. Arch Ophthalmol (1995) 0.93
Goblet-cell mucinous epithelium lining the endometrium and endocervix: evidence of metastasis from an appendiceal primary tumor through the use of cytokeratin-7 and -20 immunostains. Int J Gynecol Pathol (1998) 0.93
Progesterone receptor activity in leiomyomatosis peritonealis disseminata. Int J Gynecol Pathol (1999) 0.93
Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann Clin Lab Sci (1975) 0.93
NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. J Immunol (2000) 0.92
Cryotherapy for precancerous melanosis (atypical melanocytic hyperplasia) of the conjunctiva. Arch Ophthalmol (1981) 0.92
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecol Oncol (1994) 0.92
Femoral shaft stress fractures in athletes. Clin Sports Med (1990) 0.92
Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5'-monophosphate response elements in its expression by IL-1 and stem cell factor. J Immunol (2001) 0.90
B19 parvovirus replicates in circulating cells of acutely infected patients. Blood (1988) 0.90
Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J Immunol (1993) 0.89
Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project. Am J Obstet Gynecol (1981) 0.88
Birth weight and breast cancer risk. Br J Cancer (2006) 0.88
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy. Oncology (2004) 0.88
Torulopsis glabrata fungemia--a clinical pathological study. Medicine (Baltimore) (1979) 0.88
Mechanism of Aspergillus-induced microangiopathic hemolytic anemia. Arch Intern Med (1971) 0.88
Disseminated intravascular coagulation and renal failure: Production in the monkey with autologous red blood cell stroma. Lab Invest (1971) 0.87
A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy. Cancer Chemother Pharmacol (2010) 0.87
Experimental study of the effect of diethylstilbestrol on the development of the human female reproductive tract. Biol Res Pregnancy Perinatol (1983) 0.87
Idiopathic myelofibrosis in pregnancy: a case report and review of the literature. Am J Obstet Gynecol (1992) 0.87
Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel. Ann Oncol (2007) 0.87
Ultrastructure of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women. Cancer (1980) 0.86
K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary. Gynecol Oncol (2001) 0.86
Retrieval in a Computer-assisted Pathology Encoding and Reporting System (CAPER). Am J Clin Pathol (1981) 0.86
Substance p-fibronectin-cytokine interactions in myeloproliferative disorders with bone marrow fibrosis. Acta Haematol (2003) 0.85
Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer (1974) 0.85
Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis: perspective derived from a clinicopathologic analysis of twenty-one cases. Hum Pathol (1982) 0.85
Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings. Br J Cancer (2008) 0.85
Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med (1977) 0.85
Squamous cell neoplasia controversy in the female exposed to diethylstilbestrol. Hum Pathol (1977) 0.85
The function of lymphocytes in normal and suppressed hematopoiesis. Blut (1984) 0.84
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14. Cancer (1993) 0.84
Pulmonary cytology of the acquired immune deficiency syndrome: an analysis of 36 cases. Diagn Cytopathol (1986) 0.84